Company Profile
| name | SymBio Pharmaceuticals Limited | |
|---|---|---|
| English name | SymBio Pharmaceuticals Limited | |
| location | Toranomon 30 Mori Building, 3-2-2 Toranomon, Minato-ku, Tokyo 105-0001, Japan MAP Representative phone number: 03-5472-1125 FAX number: 03-5472-3054 |
|
| Established | March 25, 2005 | |
| capital | 17,548,459,551 yen (as of the end of December 2022) | |
| Board of Directors | Fuminori Yoshida | Reprentative Director |
| Shigetoshi Matsumoto | Board of Directors<Outside> | |
| Bruce David Cheson | Board of Directors<Outside> | |
| Eiji Ebinuma | Board of Directors<Outside> | |
| Kiyoshi Watanabe | Board Director, Full-Time Audit & Supervisory Committee Member<Outside> | |
| Kesao Endo | Board Director, Audit & Supervisory Committee Member<Outside> | |
| Yasuhiro Tamo | Board Director, Audit & Supervisory Committee Member<Outside> | |
| Corporate Officer | Fuminori Yoshida | President and Chief Executive Officer |
| Takaaki Fukushima | Executive Corporate Officer, Chief Financial Officer | |
| Koji Fukushima | Corporate Officer and Deputy CMO | |
| Masahiko Okuno | Corporate Officer | |
| Hiroyuki Horita | Corporate Officer | |
| Stephane Berthier | Corporate Officer | |
| subsidiary | SymBio Pharma USA, Inc. Durham, North Carolina, USA Stephane Berthier CEO and President |
|